What we offer

Research Areas

  • Cancer Cell Plasticity and its Dynamics
  • Circulating Tumor Cells
  • Novel drug candidates

Who are we looking for

  • An independent, self-motivated and patient person with an interest in cell and tumour biology
  • The applicants should send Curriculum Vitae and a short motivation letter, including scientific interest and future plan, diploma thesis (or its annotation) and contacts of the current supervisor and co-supervisor to Karel Souček (Tato e-mailová adresa je chráněna před spamboty. Pro její zobrazení musíte mít povolen Javascript.) by March 31, 2023. Selected candidates will be invited for an interview in the first week of April, 2023.
  • Looking forward to it! Send us your application!

Selected publications

  • Kvokackova, B., et al, K. Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Molecular Oncology 2022.
  • Muresan XM, et al. Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis. Am J Pathol 2022.
  • Drapela S, et al. The CHK1 inhibitor MU380 significantly increases sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine by induction of mitotic catastrophe. Mol Oncol 2020.
  • Remsik J, et al. Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer. Br J Cancer 2018.

Our alumni